Infectious Disease/Immunology Stimulating Access to Research in Residency (ID/IMM StARR) Program at Washington University
Infectious Disease/Immunology Stimulating Access to Research in Residency (ID/IMM StARR) Program at Washington University
批准号:
10592699
负责人:
Wayne M. Yokoyama
金额:
$41.8万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-06-16 至 2028-05-31
关键词:
AddressAdvisory CommitteesAnesthesiologyAreaAwardChildhoodClinicalClinical MedicineClinical ResearchClinical SciencesClinical and Translational Science AwardsCommunicable DiseasesCompetenceComplementDedicationsDermatologyDevelopment PlansDiscipline of obstetricsDiseaseDoctor of PhilosophyEligibility DeterminationEnsureEnvironmentEvaluationExposure toFellowshipFundingGraduate DegreeGynecologyHospitalsImmuneImmune System DiseasesImmunologyIndividualInstitutionMedicalMedical StudentsMedicineMentorsNational Institute of Allergy and Infectious DiseaseNeurologyPathologyPediatric HospitalsPediatricsPhysiciansRadiation OncologyResearchResearch PersonnelResearch TrainingResidenciesScientistSisterSpecialty BoardsTimeTrainingTraining ProgramsTranslational ResearchUnited States National Institutes of HealthUniversitiesWashingtonWomancareercareer developmentclinical trainingcohortdesigndoctoral studentfollower of religion Jewishinsightmatriculationmedical schoolsnovel therapeuticsphysician-scientist training programprogramsresearch facultysuccesstraining opportunity
中文摘要
摘要
由于他们的临床和研究培训和专业知识,内科科学家准备提供新的独特的
对疾病的洞察,最终导致治疗方面的进步。然而,有一种早已被公认的
内科医生和研究人员的短缺。虽然医学博士联合项目帮助解决了这一短缺问题,
有大量没有博士学位的医生从医学院毕业,他们形成了一个
大量潜在调查人员,以解决这一短缺问题。尤其需要内科科学家
探索感染性疾病和免疫相关疾病,获得新的治疗进展。在这里,
申请人和他的团队建议通过使用新的R38专注于非博士医生来应对这一挑战
促进传染病和免疫学住院医师研究(STAR)计划
华盛顿大学医学院(WUSM)的研究(ID/IMM STAR)。ID/IMM STAR计划
旨在为指导研究、教学培训和职业发展提供受保护的时间,这些时间将
允许居民满足董事会要求并利用WUSM稳健的环境
医生-科学家培训和ID/IMM研究。具体目标是:
目标1:为皮肤科、内科、神经科、病理学和儿科住院医师提供高素质、高能力
基础或临床/翻译ID/IMM研究方面的严格培训
目标2:提供1-2年的指导性研究培训、教学培训和其他科学充实
确保住院医生成功的职业发展活动和个人发展计划
在STARR计划中通过与杰出的科学导师密切互动,提供职业咨询
委员会和项目主管
目标3:扩大训练有素的住院医生的数量和多样性,最终进行研究,并追求
专科院士将成为传染病及免疫学的独立研究学院
目标4:进行强有力的评估和跟踪,以展示STARR计划的影响
因此,R38居民将为在ID/IMM作为独立调查人员的最终职业生涯做好充分准备
研究。
英文摘要
Abstract
Due to their clinical and research training and expertise, physician-scientists are poised to provide new unique
insights into disease, ultimately leading to advances in treatments. However, there has been a long-recognized
shortage of physician-investigators. While combined MD-PhD programs have helped address this shortage,
there are substantially more physicians without PhD degrees graduating from medical schools who form a
substantial pool of potential investigators to overcome this shortage. Physician-scientists are especially needed
to explore infectious diseases and immune-related diseases to derive new therapeutic advances. Here, the
applicant and his team propose to meet this challenge by focusing on non-PhD physicians with a new R38
Stimulating Access to Research in Residency (StARR) Program in Infectious Disease and Immunology
research (ID/IMM StARR) at Washington University School of Medicine (WUSM). The ID/IMM StARR Program
is designed to provide protected time for mentored research, didactic training, and career development that will
allow residents to fulfill board requirements and take advantage of the robust environment at WUSM for
physician-scientist training and in ID/IMM research. The Specific Aims are to:
Aim 1: Provide Dermatology, Medicine, Neurology, Pathology and Pediatric residents high quality, competency
based, rigorous training in basic or clinical/translational ID/IMM research
Aim 2: Provide 1-2 years of mentored research training, didactic training and other scientific enrichment
activities, and Individual Development Plans for career development to ensure the success of residents
in the StARR Program through close interaction with outstanding scientific mentors, career advisory
committees and program directors
Aim 3: Expand the number and diversity of well-trained residents ultimately performing research, and pursuing
subspecialty fellowships to become independent research faculty in infectious disease and immunology
Aim 4: Perform robust evaluation and tracking to demonstrate the impact of the StARR Program
Thus, R38 residents will be well-prepared for an ultimate career as independent investigators in ID/IMM
research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ORIGINS AND FUNCTIONS OF UTERINE NATURAL KILLER CELLS IN PREGNANCY
-
批准号:10451584
-
项目类别:
-
资助金额:$56.24万
-
财政年份:2018
-
负责人:Wayne M. Yokoyama
-
依托单位:
ORIGINS AND FUNCTIONS OF UTERINE NATURAL KILLER CELLS IN PREGNANCY
-
批准号:10216997
-
项目类别:
-
资助金额:$55.78万
-
财政年份:2018
-
负责人:Wayne M. Yokoyama
-
依托单位:
Translational Research Core
-
批准号:10472005
-
项目类别:
-
资助金额:$24.72万
-
财政年份:2018
-
负责人:Wayne M. Yokoyama
-
依托单位:
Translational Research Core
-
批准号:10251240
-
项目类别:
-
资助金额:$25.27万
-
财政年份:2018
-
负责人:Wayne M. Yokoyama
-
依托单位:
Translational Research Core
-
批准号:10019346
-
项目类别:
-
资助金额:$25.93万
-
财政年份:2018
-
负责人:Wayne M. Yokoyama
-
依托单位:
ORIGINS AND FUNCTIONS OF UTERINE NATURAL KILLER CELLS IN PREGNANCY
-
批准号:9762839
-
项目类别:
-
资助金额:$54.72万
-
财政年份:2018
-
负责人:Wayne M. Yokoyama
-
依托单位:
ORIGINS AND FUNCTIONS OF UTERINE NATURAL KILLER CELLS IN PREGNANCY
-
批准号:9980287
-
项目类别:
-
资助金额:$55.32万
-
财政年份:2018
-
负责人:Wayne M. Yokoyama
-
依托单位:
Natural Killer Cell Control of Murine Cytomegalovirus Infection
-
批准号:10444730
-
项目类别:
-
资助金额:$66.29万
-
财政年份:2017
-
负责人:Wayne M. Yokoyama
-
依托单位:
LIVER TISSUE-RESIDENT NATURAL KILLER CELLS
-
批准号:10116252
-
项目类别:
-
资助金额:$18.76万
-
财政年份:2017
-
负责人:Wayne M. Yokoyama
-
依托单位:
Natural Killer Cell Tolerance to Self
-
批准号:9433623
-
项目类别:
-
资助金额:$52.57万
-
财政年份:2017
-
负责人:Wayne M. Yokoyama
-
依托单位:
NATURAL KILLER CELL CONTROL OF MURINE CYTOMEGALOVIRUS INFECTION
-
批准号:10228709
-
项目类别:
-
资助金额:$53.6万
-
财政年份:2017
-
负责人:Wayne M. Yokoyama
-
依托单位:
Natural Killer Cell Tolerance to Self
-
批准号:9327124
-
项目类别:
-
资助金额:$52.83万
-
财政年份:2017
-
负责人:Wayne M. Yokoyama
-
依托单位:
LIVER TISSUE-RESIDENT NATURAL KILLER CELLS
-
批准号:9474097
-
项目类别:
-
资助金额:$19.7万
-
财政年份:2017
-
负责人:Wayne M. Yokoyama
-
依托单位:
LIVER TISSUE-RESIDENT NATURAL KILLER CELLS
-
批准号:9896769
-
项目类别:
-
资助金额:$19.08万
-
财政年份:2017
-
负责人:Wayne M. Yokoyama
-
依托单位:
NATURAL KILLER CELL CONTROL OF MURINE CYTOMEGALOVIRUS INFECTION
-
批准号:9979744
-
项目类别:
-
资助金额:$53.92万
-
财政年份:2017
-
负责人:Wayne M. Yokoyama
-
依托单位:
LIVER TISSUE-RESIDENT NATURAL KILLER CELLS
-
批准号:9245783
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2017
-
负责人:Wayne M. Yokoyama
-
依托单位:
Natural Killer Cell Tolerance to Self
-
批准号:10527376
-
项目类别:
-
资助金额:$59.43万
-
财政年份:2017
-
负责人:Wayne M. Yokoyama
-
依托单位:
NATURAL KILLER CELL CONTROL OF MURINE CYTOMEGALOVIRUS INFECTION
-
批准号:9761439
-
项目类别:
-
资助金额:$54.07万
-
财政年份:2017
-
负责人:Wayne M. Yokoyama
-
依托单位:
Natural Killer Cell Tolerance to Self
-
批准号:10364432
-
项目类别:
-
资助金额:$60.73万
-
财政年份:2017
-
负责人:Wayne M. Yokoyama
-
依托单位:
NATURAL KILLER CELL CONTROL OF MURINE CYTOMEGALOVIRUS INFECTION
-
批准号:9447919
-
项目类别:
-
资助金额:$54.81万
-
财政年份:2017
-
负责人:Wayne M. Yokoyama
-
依托单位:
海外基金